Gestala
Noninvasive ultrasound BCI startup
About
Gestala is a startup focused on developing noninvasive brain-computer interfaces (BCIs) using ultrasound technology. Their goal is to create readily accepted and commercially scalable solutions for high-prevalence conditions such as chronic pain, stroke, and depression. The company expects to roll out its first-generation product by Q3.
Similar companies
AI startup focused on automating wet-lab work for drug discovery with robots, building scientific infrastructure in the U.S.
Shares Biotech & Health
Intero Biosystems develops human intestinal organoid platforms for drug discovery, aiming to improve preclinical testing and reduce animal reliance.
Shares Biotech & Health
Developer of implantable brain-computer interfaces.
Shares Biotech & Health, Artificial Intelligence
Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.
Shares Neurotechnology
A neurotechnology company developing implantable Brain-Computer Interfaces.
Shares Neurotechnology, Artificial Intelligence
Longevity program offering personalized health protocols and AI-driven support.
Shares Biotech & Health
Key facts
- Headquarters
- China
- Founded
- 2025
- Total funding
- $22M (Unknown)
- Business model
- B2C
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Mar 2026 | Undisclosed round | $22M | Shanghai Guosheng Capital Management Co., Ltd., Dalton Venture |
Frequently asked
How much funding has Gestala raised?
Gestala has raised a total of $22M in funding. The most recent round on record is Unknown.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Gestala
